Thalidomide + Follitropin Interaction
Moderateinteraction on record
Description
Erythropoietin stimulating agents may increase thromboembolism risk when used concomitantly with thalidomide.
Mechanism
Increased thromboembolism risk
Source: NLP:thalidomide